V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005511 | 330002633 | 0 | 84 | Neo-adjuvant (N) | 2014-12-18 | 2014-12-18 | Cytarabine Low Dose | 02 | N | 330023808 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330005512 | 330002634 | null | 90.6 | Neo-adjuvant (N) | 2013-10-10 | 2013-11-20 | Paclitaxel 7 day | N | N | 330023809 | VIDE |
| 330005513 | 330002635 | 1.67 | 90 | Curative (C) | 2015-08-24 | 2015-08-24 | Hydroxycarbamide | 2 | N | 330023810 | MITOTANE |
| 330005514 | 330002635 | 1.62 | null | Disease modification (D) | 2015-06-13 | 2015-06-16 | R Chlorambucil | 2 | null | 330023810 | IFOSFAMIDE |
| 330005515 | 330002636 | null | 93.8 | Curative (C) | 2015-09-13 | 2015-10-23 | Cyclophosphamide oral | N | Y | 330023816 | DOXORUBICIN + IFOSFAMIDE |
| 330005516 | 330002636 | 1.55 | 102.5 | Not known (9) | 2014-11-14 | 2014-11-15 | Hydroxycarbamide | Y | N | 330023816 | EC |
| 330005517 | 330002636 | 1.75 | 77.3 | Palliative (P) | 2013-12-13 | 2013-12-14 | ECE | 2 | N | 330023816 | CHOP R |
| 330005518 | 330002636 | 0.77 | 39.7 | Palliative (P) | 2015-02-24 | 2015-02-25 | Cladribine (subcut) 5 days | 02 | N | 330023816 | TEMOZOLOMIDE |
| 330005519 | 330012274 | null | 96.3 | null | 2017-06-24 | 2017-07-08 | VIP | N | Y | 330023833 | AZACITIDINE |
| 330005520 | 330002637 | null | 63 | Curative (C) | 2015-06-13 | 2015-06-23 | Temozolomide + RT | 02 | N | 330023842 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330005521 | 330007443 | null | 61.1 | Palliative (P) | 2013-03-25 | 2013-05-03 | Doxorubicin + Olaratumab | N | null | 330023851 | CHLORAMBUCIL |
| 330005522 | 330007443 | 1.64 | 105 | Neo-adjuvant (N) | 2014-12-18 | 2014-12-26 | CARBOPLATIN + RT | 02 | N | 330023851 | AZACITIDINE |
| 330005523 | 330007443 | 0 | 68.5 | Curative (C) | 2015-02-06 | 2015-02-10 | MIFAMURTIDE | 02 | null | 330023851 | UKALL2011 |
| 330005524 | 330007443 | 1.58 | 76.2 | Palliative (P) | 2016-02-03 | 2016-03-03 | BEP 5 Day | 02 | N | 330023851 | BEP |
| 330005525 | 330007443 | 1.46 | 95.1 | Adjuvant (A) | 2013-04-09 | 2013-04-10 | Cyclophosphamide + Vincristine | Y | N | 330023851 | RUXOLITINIB |
| 330005526 | 330007443 | 1.63 | 85.7 | null | 2015-01-03 | 2015-01-03 | Hydroxycarbamide | N | N | 330023851 | OXALIPLATIN + MDG |
| 330005530 | 330002639 | null | 0 | Palliative (P) | 2017-11-03 | 2017-11-06 | AML 19 TRIAL | 02 | null | 330023892 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE |
| 330005531 | 330007445 | 0 | null | Palliative (P) | 2016-06-16 | 2016-06-16 | BEP 3 day | N | N | 330023893 | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN |
| 330005532 | 330002640 | 0 | 59 | Curative (C) | 2014-03-14 | 2014-03-27 | METHOTREXATE | 02 | Y | 330023895 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 330005533 | 330002641 | 0 | 48.6 | Adjuvant (A) | 2014-11-11 | 2014-12-08 | Hydroxycarbamide | N | null | 330023900 | DOCETAXEL + GEMCITABINE |
| 330005534 | 330002641 | 1.6 | 68.9 | Curative (C) | 2014-07-05 | 2014-07-05 | BEP 3 day | N | N | 330023900 | ECX |
| 330005535 | 330002642 | 1.62 | 58.1 | Neo-adjuvant (N) | 2014-06-19 | 2014-06-22 | AFATINIB | N | N | 330023905 | DOCETAXEL + GEMCITABINE |
| 330005536 | 330002642 | null | null | Disease modification (D) | 2017-08-10 | 2017-08-24 | BEP 3 day | N | Y | 330023905 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330005537 | 330002643 | 1.82 | 53.7 | Palliative (P) | 2014-11-22 | 2014-12-04 | Bendamustine + prednisolone | 02 | N | 330023923 | IVA |
| 330005538 | 330002644 | null | null | Palliative (P) | 2017-05-22 | 2017-05-22 | UKALL14- Ph 1 Induction | N | N | 330023929 | UKALL2011 |
| 330005539 | 330002645 | 1.64 | 96.5 | Palliative (P) | 2014-10-08 | 2014-10-08 | AML17 TRIAL | N | N | 330023933 | CHLORAMBUCIL |
| 330005540 | 330002646 | 1.55 | 96.45 | null | 2017-10-07 | 2017-10-07 | METHOTREXATE | null | N | 330023935 | DOXORUBICIN + IFOSFAMIDE |
| 330005541 | 330002647 | null | 90 | null | 2016-03-22 | 2016-03-24 | Cisplatin + Docetaxel | null | null | 330023939 | IVA |
| 330005542 | 330002648 | 1.53 | 114 | Adjuvant (A) | 2016-01-04 | 2016-01-11 | VIDE | 2 | N | 330023942 | METHOTREXATE |
| 330005543 | 330002649 | 1.7 | 95.1 | Disease modification (D) | 2013-09-03 | 2013-09-11 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330023947 | TEMOZOLOMIDE + RT |
| 330005544 | 330002650 | null | null | Curative (C) | 2016-02-26 | 2016-03-04 | Cisplatin + Docetaxel | N | null | 330023951 | AML19 TRIAL |
| 330005546 | 330002651 | 1.72 | 97.3 | null | 2015-12-07 | 2015-12-08 | POMB/ACE | N | null | 330023962 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330005547 | 330002652 | 1.6 | 64.5 | Palliative (P) | 2015-04-18 | 2015-04-18 | Azacitidine | N | N | 330023967 | CISPLATIN + FLUOROURACIL + RT |
| 330005548 | 330007449 | 1.82 | 70.4 | null | 2014-11-25 | 2014-12-09 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330023970 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330005549 | 330007449 | 1.58 | 61.7 | Disease modification (D) | 2014-08-29 | 2014-09-17 | Temozolomide + RT | 02 | N | 330023970 | CISPLATIN + DOX + ETOPOSIDE |
| 330005550 | 330002653 | 1.75 | null | Disease modification (D) | 2013-12-19 | 2014-01-19 | VDC | N | N | 330023981 | BORTEZOMIB |
| 330005551 | 330002654 | null | 75.8 | Curative (C) | 2016-10-01 | 2016-10-03 | Dacarbazine | N | null | 330023993 | UKALL2014 |
| 330005552 | 330002654 | 1.71 | 68.7 | Palliative (P) | 2016-03-12 | 2016-03-16 | ALL UKALL2011 IndB Std Dex (PegAsp) | 02 | N | 330023993 | CARBOPLATIN + VINCRISTINE |
| 330005553 | 330002654 | 1.68 | 81.4 | Curative (C) | 2018-05-26 | 2018-05-26 | Mitotane 2g | 02 | N | 330023993 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 330005554 | 330002654 | 1.62 | null | null | 2017-02-27 | 2017-03-02 | Cisplatin + Docetaxel | N | N | 330023993 | GEMCITABINE |
| 330005555 | 330002655 | null | 82.2 | Curative (C) | 2013-05-31 | 2013-05-31 | THALIDOMIDE | null | N | 330024003 | DOCETAXEL + GEMCITABINE |
| 330005556 | 330007451 | 1.57 | 97.5 | Palliative (P) | 2017-06-06 | 2017-06-20 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | 330024004 | TEMOZOLOMIDE |
| 330005557 | 330007451 | 0 | 65.5 | Curative (C) | 2013-06-14 | 2013-06-18 | PEMBROLIZUMAB | N | N | 330024004 | AML16 TRIAL |
| 330005558 | 330002656 | 1.62 | null | null | 2013-12-27 | 2013-12-28 | Hydroxycarbamide | Y | N | 330024031 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 330005559 | 330002656 | 1.54 | 47.5 | Adjuvant (A) | 2014-09-09 | 2014-09-23 | AML16 DA 3+10 | N | Y | 330024031 | PAZOPANIB |
| 330005560 | 330002656 | 1.67 | null | Palliative (P) | 2014-06-09 | 2014-06-09 | Chlorambucil | N | N | 330024031 | CARBOPLATIN + DOXORUBICIN |
| 330005561 | 330002656 | 1.71 | 56.8 | Palliative (P) | 2015-12-29 | 2015-12-31 | Cyclophosphamide+Fludara+TBI Allo | N | N | 330024031 | VIDE |
| 330005562 | 330002656 | 0.96 | null | Neo-adjuvant (N) | 2013-08-04 | 2013-08-13 | BEP 5 Day | Y | N | 330024031 | UKALL2011 |
| 330005563 | 330002657 | 1.72 | 86.6 | Palliative (P) | 2016-08-04 | 2016-08-17 | FLAG + Idarubicin | Y | N | 330024052 | RUXOLITINIB |
| 330005564 | 330002658 | 1.76 | 98.5 | Palliative (P) | 2015-09-05 | 2015-09-09 | ICE | 2 | N | 330024054 | CHOP R |